The use of human induced pluripotent stem cells to screen for developmental toxicity potential indicates reduced potential for non-combusted products, when compared to cigarettes

Autor: Fan Yu, Roman Wieczorek, Edgar Trelles Sticken, Matthew Stevenson, Kathryn Rudd, Lukasz Czekala, Fiona Chapman, Lisa Maria Bode, Liam Simms, Tanvir Walele, Jessica Palmer
Rok vydání: 2020
Předmět:
Health
Toxicology and Mutagenesis

OECD
Organisation for Economic Co-operation and Development

Developmental toxicity
HTP
heated tobacco product

Pharmacology
Toxicology
Applied Microbiology and Biotechnology
Nicotine
EVP
electronic vapour product

chemistry.chemical_compound
HPLC-DAD
high-performance liquid chromatography with a diode-array detector

Induced pluripotent stem cell
Cytotoxicity
CDC
Centers for Disease Control and Prevention

ISO
International Organization for Standardisation

Human induced pluripotent stem cells
Q-TOF
Quadrupole Time-of-Flight

EPA
United States Environmental Protection Agency

bPBS
bubbled phosphate buffered saline

E-cigarettes
TT21C
toxicity testing in the 21st century

iPS cells
induced pluripotent stem cells

COT
United Kingdom Committee on Toxicity of Chemicals in Food
Consumer Products and the Environment

medicine.drug
DART
developmental and reproductive toxicity

NICE
National Institute for Health and Care Excellence

NHS
United Kingdom National Health Service

FDR
false discovery rate

ECVAM
European Center for the Validation of Alternative Methods

nAChRs
nicotinic acetylcholine receptors

Article
ROS
reactive oxygen species

PBS
phosphate buffered saline

lcsh:RA1190-1270
medicine
devTOXqP
devTOX quickPredict

Viability assay
HYB
hybrid product

o/c
ornithine/cystine ratio

e-cigarettes
electronic cigarettes

lcsh:Toxicology. Poisons
ComputingMethodologies_COMPUTERGRAPHICS
Smoke
LOQ
limit of quantification

PG/VG
propylene glycol/vegetable glycerine

Cigarettes
TP
cell viability toxicity potential concentration

CV
coefficient of variation

UPLC-HRMS
ultra-high performance liquid chromatography coupled high resolution mass spectrometry

DNPH
2
4-dinitrophenylhydrazine

Embryonic stem cell
In vitro reproduction assay
POD
point of difference

chemistry
HPHCs
Harmful and Potentially Harmful Constituents

ISTD
internal standard

dTP
developmental toxicity potential concentration

ODC
ornithine decarboxylase

ND
No effect was detected within the exposure range tested

ATRA
All-trans-retinoic acid

dTT
developmental toxicity threshold

LC-MS/MS
liquid chromatography with tandem mass spectrometry

Toxicant
Zdroj: Current Research in Toxicology
Current Research in Toxicology, Vol 1, Iss, Pp 161-173 (2020)
ISSN: 2666-027X
Popis: Graphical abstract
Highlights • Effective in vitro strategies are required to predict early developmental toxicity. • devTOXqP is a metabolomics biomarker assay using iPSCs. • Sample smoke/aerosol captured in bPBS, was tested up to 10% concentration. • Cigarettes & HTP bPBS extracts were predicted as potentially developmentally toxic. • HYB & EVP aerosols were not predicted as having developmentally toxic potential in devTOXqP.
devTOX quickPredict (devTOXqP) is a metabolomics biomarker-based assay that utilises human induced pluripotent stem (iPS) cells to screen for potential early stage embryonic developmental toxicity in vitro. Developmental toxicity potential is assessed based on the assay endpoint of the alteration in the ratio of key unrelated biomarkers, ornithine and cystine (o/c). This work aimed to compare the developmental toxicity potential of tobacco-containing and tobacco-free non-combustible nicotine products to cigarette smoke. Smoke and aerosol from test articles were produced using a Vitrocell VC10 smoke/aerosol exposure system and bubbled into phosphate buffered saline (bPBS). iPS cells were exposed to concentrations of up to 10% bPBS. Assay sensitivity was assessed through a spiking study with a known developmental toxicant, all-trans-retinoic acid (ATRA), in combination with cigarette smoke extract. The bPBS extracts of reference cigarettes (1R6F and 3R4F) and a heated tobacco product (HTP) were predicted to have the potential to induce developmental toxicity, in this screening assay. The bPBS concentration at which these extracts exceeded the developmental toxicity threshold was 0.6% (1R6F), 1.3% (3R4F), and 4.3% (HTP) added to the cell media. Effects from cigarette smoke and HTP aerosol were driven largely by cytotoxicity, with the cell viability and o/c ratio dose–response curves crossing the developmental toxicity thresholds at very similar concentrations of added bPBS. The hybrid product and all the electronic cigarette (e-cigarette) aerosols were not predicted to be potential early developmental toxicants, under the conditions of this screening assay.
Databáze: OpenAIRE